Related Experiment Video
Updated: Sep 18, 2025

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients With Diverse Immunological Risks Under
Mun Chae Choi1,2, Minyu Kang3,4, Hwa-Hee Koh3,4
1Department of Surgery, Armed Forces Capital Hospital, Seongnam, South Korea.
Abstract:
Cytomegalovirus (CMV) infection remains the most prevalent viral infection in kidney transplant recipients. Despite effective preventive strategies, the use of desensitization therapies and potent immunosuppressive agents in patients with high immunological risks underscores the continued importance of CMV as a major concern. This study aims to determine the incidence and outcomes of CMV infection in patients with diverse immunological risks under preemptive stategies. We analyzed 614 CMV-seropositive kidney transplant recipients managed under preemptive strategies. Of them, 231 patients (37.6%) underwent immunologically incompatible transplantation, including 75 ABO- and 156 HLA-incompatible transplants. During the median follow-up of 60 months, 354 patients (57.7%) experienced CMV infection. Multivariable analysis identified older recipient age, deceased donor, rituximab, and anti-thymocyte globulin as independent risk factors for CMV infection, while the use of mammalian target of rapamycin inhibitor was protective. Multivariable Cox regression analysis confirmed that CMV infection was independently associated with increased risks of death-censored graft loss (adjusted hazard ratio [aHR], 2.05; 95% confidence interval [CI], 1.17-3.59) and all-cause mortality (aHR, 3.40; 95% CI, 1.60-7.23). CMV infection adversely affects graft and patient outcomes in seropositive recipients managed under preemptive strategies. These findings emphasize the need for optimized CMV prevention strategies in recipients with high immunological risks, hereby intensified preemptive strategies or immunological risk-adapted antiviral prophylaxis are key options.
Insights
Cytomegalovirus (CMV) infection significantly impacts kidney transplant recipients, increasing risks of graft loss and mortality. Optimized prevention strategies are crucial, especially for high-risk patients undergoing preemptive management.
Area of Science:
- Nephrology
- Transplantation Immunology
- Infectious Diseases
Background:
- Cytomegalovirus (CMV) infection is the most common viral infection post-kidney transplant.
- High-risk patients often receive potent immunosuppression, increasing CMV concern.
- Preemptive strategies are used, but CMV incidence and outcomes require further study.
Purpose of the Study:
- To determine the incidence and outcomes of CMV infection in kidney transplant recipients with varying immunological risks.
- To evaluate the effectiveness of preemptive strategies in managing CMV.
- To identify risk factors and protective elements associated with CMV infection.
Main Methods:
- Analysis of 614 CMV-seropositive kidney transplant recipients on preemptive strategies.
- Inclusion of patients with immunologically incompatible transplants (ABO and HLA).
- Median follow-up of 60 months with multivariable and Cox regression analyses.
Main Results:
- CMV infection occurred in 57.7% of patients.
- Independent risk factors included older recipient age, deceased donor, rituximab, and anti-thymocyte globulin.
- Mammalian target of rapamycin inhibitor use was protective against CMV infection.
Conclusions:
- CMV infection is independently associated with increased risk of death-censored graft loss and all-cause mortality.
- Findings highlight the need for optimized CMV prevention in high-risk kidney transplant recipients.
- Intensified preemptive strategies or risk-adapted prophylaxis are recommended.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cell-mediated Immune Responses

